FDA Delays Final Approval of Novavax COVID Vaccine
Medically reviewed by Drugs.com.
By I. Edwards HealthDay Reporter
FRIDAY, April 4, 2025 -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine.
The decision had been expected by April 1, but the agency now says it needs more information before moving forward.
The Novavax shot is already available under emergency use. But full FDA approval would allow the vaccine to be used more widely and could offer more reassurance to people looking for options besides the existing mRNA vaccines, CNN reported.
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal approval for mRNA-based COVID shots, which President Donald Trump has touted as a key first- term achievement.
Novavax uses protein-based technology, a more traditional method than the mRNA vaccines from Pfizer and Moderna.
“As of Tuesday, April 1, we had responded to all of the FDA’s information requests and we believe that our [Biologics License Application] is ready for approval,” Novavax said in a statement, adding that its application “included robust Phase 3 clinical trial data that showed our vaccine is safe and effective for the prevention of COVID-19.”
“We are confident our well-tolerated vaccine represents an important alternative to mRNA COVID-19 vaccines for the U.S.,” Novavax added.
The delay comes as the FDA is undergoing leadership changes. Dr. Scott Steele was recently named acting director of the FDA’s vaccine division after Dr. Peter Marks stepped down last month.
U.S. Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., who has long opposed vaccines, has made false claims about the COVID shots and recently shared misleading information about the measles vaccine -- which came amid a deadly measles outbreak.
An HHS spokesman told CNN, “the FDA’s independent review process for the Novavax vaccine, like all vaccines is based solely on ensuring safety and efficacy, not political considerations. Any delays are a result of scientific review.”
The FDA’s press office was also placed on administrative leave this week as part of a government downsizing effort.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-04-05 00:00
Read more

- Paxlovid May Offer Little Benefit for Vaccinated Older Adults
- Death Risk Higher Among People With Arthritis And COPD
- Combination, Aerobic Exercise Improves Sleep Quality in Seniors
- FDA Increases Testing For Heavy Metals In Baby Formula
- PDS Biotech Initiates VERSATILE-003 Phase 3 Clinical Trial Evaluating Versamune HPV in HPV16-Positive Head and Neck Cancer
- Nose Cartilage Can Help Repair Knee Injuries, Researchers Say
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions